Ligand validation:6GAR

OXM: OXAMIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GAR_OXM_A_403	60%	16%	0.111	0.896	2.51	1.23	1	-	0	0	100%	1
6GAR_OXM_B_402	42%	15%	0.159	0.878	2.85	0.96	2	-	0	0	100%	1
8C3M_OXM_A_402	16%	16%	0.247	0.82	1.6	2.06	1	2	0	0	100%	1
4PLT_OXM_A_402	98%	9%	0.057	0.98	2.48	2.07	1	2	2	0	100%	1
1H17_OXM_A_1001	97%	6%	0.057	0.974	3.66	1.35	1	1	1	0	100%	1
6CIB_OXM_E_403	97%	12%	0.059	0.973	3.33	0.84	2	-	1	0	100%	1
5YTA_OXM_B_402	97%	15%	0.064	0.977	1.86	1.9	1	1	0	0	100%	1
3H3F_OXM_F_333	96%	11%	0.071	0.979	2.35	1.89	1	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.